Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4

Journal article

Peer reviewed

A. R. N. Zekri, H. A. Haleem, G. E. -D. Esmat, A. A. Bahnassy, H. M. A. El-Din, M. M. Hafez, A. F. Sharaby, H. Sharaf and M. S. E.-D. Zakaria

Journal of viral hepatitis, Vol.14(7), pp.468-477

Received July 2006; accepted for publication September 2006

07/2007

PMID: 17576388

Abstract

Fas-L

genotype-4

HCV

IFN

sFas

TNFR

1 Record Views

Title: Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4
Creators - without role: A. R. N. Zekri - Cairo University
H. A. Haleem - Cairo University
G. E. -D. Esmat - Cairo University
A. A. Bahnassy - Cairo University
H. M. A. El-Din - Cairo University
M. M. Hafez - Cairo University
A. F. Sharaby - Cairo University
H. Sharaf - Cairo University
M. S. E.-D. Zakaria - Cairo University
Publication Details: Journal of viral hepatitis, Vol.14(7), pp.468-477
Publisher: Blackwell Publishing Ltd
Edition: Received July 2006; accepted for publication September 2006
Number of pages: 10
Identifiers: 9911673508331
Academic Unit: Taif University
Language: English
Resource Type: Journal article